We have provided new insights into the molecular mechanism for UBQLN2 actions in radiosensitivity, which mediates DNA-PKcs to block the NHEJ repair of DNA damages induced by irradiation and activating the downstream molecule p38 MAPK, which might have a great implication in developing more effective cancer radiotherapy. This evidence concerns the gene UBQLN2 and cancer.